Concentric Medical closes $15M to ease stroke symptoms
Concentric Medical, developer of minimally invasive devices used to remove blood clots in ischemic stroke patients, took $15 million in new venture backing to expand its product portfolio and run more clinical trials. The Mountain View, Calif. company says it ended 2008 on a strong financial note that helped attract investors despite the tight economy. This is an uptick from February, when it withdrew its plans for a $69 million initial public offering.
Concentric Medical’s devices are comprised of catheters that are inserted into a patient’s arteries to the brain, where a wire coils around clots and carefully removes them. This model has been known to malfunction and cause additional blood vessel damage, according to past VentureBeat coverage.
New Enterprise Associates led the recent round. The company had previously raised $53 million from NEA, SV Life Sciences, Oxford Bioscience Partners and ProQuest Investments.
Next Story: The new prolific iPhone app developer: Microsoft
Previous Story: SpectraLinear nabs $9.8M for computing timers
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.